• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Saturday, June 27, 2026
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News Chemistry

Protein in blood protects against neuronal damage after brain hemorrhage

Bioengineer by Bioengineer
October 21, 2019
in Chemistry
Reading Time: 3 mins read
0
IMAGE
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

IMAGE

Credit: Dominik Schaer, UZH/USZ

Patients who survive a cerebral hemorrhage may suffer delayed severe brain damage caused by free hemoglobin, which comes from red blood cells and damages neurons. Researchers at the University of Zurich and the UniversityHospital Zurich have now discovered a protective protein in the body called haptoglobin, which prevents this effect.

Bleeding in the narrow space between the inner and middle meninges is life threatening. This type of cerebral hemorrhage is normally caused by small protrusions in the major arteries at the base of the brain (Aneurysms) that can burst without warning. A third of patients suffering such a hemorrhage, who are often still young, die as a result of the massive increase of pressure inside the skull. “Even if we manage to stop the bleeding and to stabilize the patients, in the first two weeks after bleeding there can be delayed brain damage. This often leads to severe impairments or can even be fatal,” explains Luca Regli, director of the Department of Neurosurgery at the UniversityHospital Zurich (USZ).

Free hemoglobin in the cerebrospinal fluid damages neurons

Despite great research efforts, until now it has not been possible to prevent these serious consequences of bleeding in the subarachnoid space. An interdisciplinary team of researchers from the University of Zurich (UZH), USZ and the Veterinary Teaching Hospital Zurich have now discovered a promising strategy: Haptoglobin, a protective protein found in the blood, binds the hemoglobin that has been released in the cerebrospinal fluid before it can cause damage.

“We observed that in the days after the bleeding, the accumulated blood slowly resolves and the hemoglobin from the degraded red blood cells gets into the cerebrospinal fluid,” says Emanuela Keller, head of the neurosurgery intensive care unit at USZ. This protein, which is normally responsible for transporting oxygen, plays an important role in the occurrence of delayed neurological damage. “Using patient samples and tests on sheep, we have now been able to show that the hemoglobin leads to vasospasms and penetrates deep into the brain tissue, where it can directly damage neurons,” says study lead Dominik Schaer, UZH professor and chief of service in the Department of Internal Medicine at USZ.

Haptoglobin binds hemoglobin and renders it harmless

The substance that makes hemoglobin so dangerous is iron, which is found in the center of the protein and has a high propensity to undergo chemical reactions. Diseases such as malaria, in which hemoglobin is also released, have led to the human body, in the course of evolution, forming its own protective protein called haptoglobin. In the blood, haptoglobin binds free hemoglobin, thus preventing its toxic effects in blood vessels and kidneys. However, the concentration of haptoglobin in the brain is very low and does not offer enough protection against a cerebral hemorrhage.

By administering purified haptoglobin directly into the cerebrospinal fluid of sheep via a catheter, the researchers were now able to make use of this natural protective mechanism. “We could show that purified haptoglobin prevents vasospasms and blocks free hemoglobin from penetrating the brain tissue,” explains Dominik Schaer.

Discovery enables new treatment approach

For patients who suffer bleeding in the subarachnoid space, these results have great medical potential: “We have found a possibility to potentially prevent the toxicity of free hemoglobin after intracranial hemorrhage. This could significantly improve the neurological prognosis and the long-term quality of life for those affected,” says neurosurgeon and first author of the study Michael Hugelshofer.

###

Media Contact
Dr. Dominik Schaer
[email protected]
41-442-552-382

Original Source

https://www.media.uzh.ch/en/Press-Releases/2019/Haptoglobin.html

Related Journal Article

http://dx.doi.org/10.1172/JCI130630

Tags: BiochemistryBiologyCardiologyCell BiologyMedicine/HealthStroke
Share12Tweet8Share2ShareShareShare2

Related Posts

AI and Physics Collaborate to Design Advanced Hydrogen Storage Materials

June 25, 2026

International Team Including Dresden Scientists Develops Novel Designer Proteins for Advanced Study of Living Tissue

June 25, 2026

New Study Uncovers Key Factors Driving Water Chemistry in Nanoscale Environments

June 25, 2026

Plasma Technology Extends Catalyst Lifespan in Hydrogen Production

June 24, 2026
Please login to join discussion

POPULAR NEWS

  • Saying Goodbye to PGY-6: Pediatric Fellowship Realities

    103 shares
    Share 41 Tweet 26
  • Multi-Hospital Study Reveals Long Covid Burden Is Twice as High as Current Estimates

    92 shares
    Share 36 Tweet 23
  • Detection of EDCs in Breast Milk and Infant Urine Up to Six Months Highlights Early Exposure Risks

    77 shares
    Share 31 Tweet 19
  • New Drug Candidate Developed at McMaster Shows Potential for Treating Brain Cancer

    58 shares
    Share 23 Tweet 15

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Tracking Lanthanide-Labeled Microplastics in Plants

POSTECH Researchers Slash Cost of Reconstituted Cell-Free Systems by 95%

AI and Physics Collaborate to Design Advanced Hydrogen Storage Materials

Subscribe to Blog via Email

Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm' to start subscribing.

Join 82 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.